Vectorial delivery of macromolecules into cells using peptide-based vehicles

Trends in Biotechnology

Volumn 19, Issue 1, 2001, Pages 21-28

  Gariépy, Jean ^a   Kawamura, Kim ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DNA; PEPTIDE; VIRUS VECTOR;

ARTICLE; CELL ORGANELLE; CELL SURFACE; EUKARYOTIC CELL; GENE TARGETING; MACROMOLECULE; MOLECULAR DYNAMICS; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

EUKARYOTA;

EID: 0035182518     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7799(00)01520-1     Document Type: Review

References (100)

1. Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein
2. In vivo protein transduction: Delivery of a biologically active protein into the mouse
3. In vivo protein transduction: Intracellular delivery of biologically active proteins, compounds and DNA
4. Cell-penetrating peptides
5. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells
6. Enhanced cellular uptake of oligonucleotides by EGF receptor-mediated endocytosis in A549 cells
7. Methotrexate-poly(lysine) as a selective agent for mutants of Chinese hamster ovary cells defective in endocytosis
8. Poly (L-lysine) and poly (D-lysine) conjugates of methotrexate: Different inhibitory effect on drug resistant cells
9. Conjugation of poly-L-lysine to albumin and horseradish peroxidase: A novel method of enhancing the cellular uptake of proteins
10. Interaction of DNA with lysine-rich polypeptides and proteins. The influence of polypeptide composition and secondary structure
11. Carrier design: Biodistribution of branched polypeptides with a poly(L-lysine) backbone
12. Poly(L-lysine)-conjugated oligonucleotides promote sequence-specific inhibition of acute HIV-1 infection
13. Oligonucleotide-poly(L-lysine)-heparin complexes: Potent sequence-specific inhibitors of HIV-1 infection
14. Biological activity of oligonucleotide-poly(L-lysine) conjugates: Mechanism of cell uptake
15. Evidence for the role of proteoglycans in cation-mediated gene transfer
16. Effects of synthetic polycations on leucine incorporation, lactate dehydrogenase release, and morphology of human umbilical vein endothelial cells
17. Biochemical characterisation of polycation-induced cytotoxicity to human vascular endothelial cells
18. Antineoplastic activity of poly(L-lysine) with some ascites tumour cells
19. Conjugates of folate and anti-T-cell-receptor antibodies specifically target folate-receptor-positive tumour cells for lysis
20. Delivery of macromolecules into living cells: A method that exploits folate receptor endocytosis
21. Cellular import of functional peptides to block intracellular signaling
22. Hydrophobic content and lipid interactions of wild-type and mutant OmpA signal peptides correlate with their in vivo function
23. Genetic engineering of proteins with cell membrane permeability
24. Identification of a functionally important sequence in the cytoplasmic tail of integrin beta 3 by using cell-permeable peptide analogs
25. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence
26. A new peptide vector for efficient delivery of oligonucleotides into mammalian cells
27. A novel potent strategy for gene delivery using a single peptide vector as a carrier
28. Molecular mechanisms of protein secretion: The role of the signal sequence
29. +-induced membrane insertion of influenza virus hemagglutinin involves the HA2 amino-terminal fusion peptide but not the coiled coil region
30. Membrane destabilizing activity of influenza virus hemagglutinin-based synthetic peptide: Implications of critical glycine residue in fusion peptide
31. Structure and topology of the influenza virus fusion peptide in lipid bilayers
32. Mechanism of leakage of phospholipid vesicle contents induced by the peptide GALA
33. Association of a pH-sensitive peptide with membrane vesicles: Role of amino acid sequence
34. Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers
35. Chain length of cationic α-helical peptide sufficient for gene delivery into cells
36. Effect of amino acid substitution in amphiphilic alpha-helical peptides on peptide-phospholipid membrane interaction
37. The third helix of the Antennapedia homeodomain translocates through biological membranes
38. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent
39. Cell penetration by transportan
40. Endocytosis and targeting of exogenous HIV-1 Tat protein
41. Tat-mediated delivery of heterologous proteins into cells
42. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus
43. Sequence requirements for nuclear location of simian virus 40 large-T antigen
44. A short amino acid sequence able to specify nuclear location
45. Induction of nuclear transport with a synthetic peptide homologous to the SV40 T antigen transport signal
46. Synthetic peptides as nuclear localization signals
47. Ionic channels formed by a primary amphipathic peptide containing a signal peptide and a nuclear localization sequence
48. Design of carrier peptide-oligonucleotide conjugates with rapid membrane translocation and nuclear localization properties
49. Nuclear targeting peptide scaffolds for lipofection of nondividing mammalian cells
50. Enhancement of polylysine-mediated transferrinfection by nuclear localization sequences: Polylysine does not function as a nuclear localization sequence
51. The arginine-rich domains present in human immunodeficiency virus type 1 Tat and Rev function as direct importin beta-dependent nuclear localization signals
52. Definition of a consensus transportin-specific nucleocytoplasmic transport signal
53. Loligomers: Design of de novo peptide-based intracellular vehicles
54. Penetration and intracellular routing of nucleus-directed peptide-based shuttles (loligomers) in eukaryotic cells
55. Peptide-based intracellular shuttle able to facilitate gene transfer in mammalian cells
56. Potentiation of chlorin e6 photodynamic activity in vitro with peptide-based intracellular vehicles
57. 'Peptabody': A new type of high avidity binding protein
58. Insulin-mediated intracellular targeting enhances the photodynamic activity of chlorin e6
59. Nuclear targeting of chlorin e6 enhances its photosensitizing activity
60. Receptor-mediated transfection of murine and ovine mammary glands in vivo
61. Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers
62. Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers
63. Self-assembling dendrimers
64. Comparison of the B-pentamers of heat-labile enterotoxin and verotoxin-1: Two structures with remarkable similarity and dissimilarity
65. Lactose binding to heat-labile enterotoxin revealed by X-ray crystallography
66. Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3
67. Solution structure of the complex between the B-subunit homopentamer of verotoxin VT-1 from Escherichia coli and the trisaccharide moiety of globotriaosylceramide
68. Multimeric forms of Tyr-Ile-Gly-Ser-Arg (YIGSR) peptide enhance the inhibition of tumour growth and metastasis
69. The effect of protein context on nuclear location signal function
70. The effects of variations in the number and sequence of targeting signals on nuclear uptake
71. Receptor-mediated endocytosis of transferrin-polycation conjugates: An efficient way to introduce DNA into hematopoietic cells
72. Receptor-targeted transfection using stable maleimido-transferrin/thio-poly-L-lysine conjugates
73. Binding of enkephalin/dextran conjugates to opioid receptors
74. Preparation and purification of an end to end coupled mEGF-dextran conjugate
75. Effects of dextranation on the pharmacokinetics of short peptides. A PET study on mEGF
76. Synthesis and characterization of polymer-(multi)-peptide conjugates for control of specific cell aggregation
77. Peptide attachment to extremities of liposomal surface grafted PEG chains: Preparation of the long-circulating form of laminin pentapeptide, YIGSR
78. Dependence of ricin toxicity on translocation of the toxin A-chain from the endoplasmic reticulum to the cytosol
79. Modification of ricin A chain, by addition of endoplasmic reticulum (KDEL) or Golgi (YQRL) retention sequences, enhances its cytotoxicity and translocation
80. C- to N-terminal translocation of preproteins into mitochondria
81. Synthetic peptide vaccine design: Synthesis and properties of a high-density multiple antigenic peptide system
82. Multiple antigen peptide system
83. Branched cationic peptides for gene delivery: Role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes
84. Cellular immune responses induced by in vivo priming with a lipid-conjugated multimeric antigen peptide
85. Ganglioside conjugate vaccines. Immunotherapy against tumours of neuroectodermal origin
86. Solid-phase synthesis and applications of N-(S-acetylmercaptoacetyl) peptides
87. A new synthetic functionalized antigen carrier
88. Simultaneous multiple synthesis and selective conjugation of cyclized peptides derived from a surface loop of a meningococcal class 1 outer membrane protein
89. The HIV-1 Tat nuclear localization sequence confers novel nuclear import properties
90. A leucine-rich nuclear export signal in the p53 tetramerization domain: Regulation of subcellular localization and p53 activity by NES masking
91. Trojan peptides: The penetratin system for intracellular delivery
92. Interaction of Pex5p, the type 1 peroxisome targeting signal receptor, with the peroxisomal membrane proteins Pex14p and Pex13p
93. Protein transport into mitochondria
94. Coiled coils: New structures and new functions
95. Structure, function and application of the coiled-coil protein folding motif
96. Self-assembled peptides exposing epitopes recognizable by human lymphoma cells
97. Recent advances in the design and construction of synthetic peptides: For the love of basics or just for the technology of it
98. Preparation of functionally active cell-permeable peptides by single-step ligation of two peptide modules
99. Intercellular delivery of functional p53 by the herpes virus protein VP22